Alan Rapoport
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 17, 2025
Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.Stephanie J Nahas, Marius Birlea, Alit Stark-Inbar
|Sep 12, 2025
Optimising combined treatment for migraine and temporomandibular disorders (TMDs).Marcela Romero-Reyes, Simon Akerman, Alan M Rapoport
|Oct 07, 2024
Continuing evolution of migraine-specific therapies - targeting migraine with precision and persistence.Dimos D Mitsikostas, Alan Rapoport
|Oct 07, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.Stewart J Tepper, Detlef Albrecht, Jessica Ailani
|Jul 12, 2023
The 5-HT<sub>1F</sub> receptor as the target of ditans in migraine - from bench to bedside.Dimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio
|Apr 12, 2023
Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older.Mahsa Babaei, Alan M Rapoport
Pageof 2
Frequent Collaborators
2 joint publications
Dimos D Mitsikostas
1 joint publications
Christina Sun-Edelstein
1 joint publications
Anan Srikiatkhachorn
1 joint publications
Richard B Lipton
1 joint publications
Stewart J Tepper
1 joint publications
Detlef Albrecht
1 joint publications
Jessica Ailani
1 joint publications
Marcela Romero-Reyes
1 joint publications
Simon Akerman
1 joint publications
Stephanie J Nahas
